Peloruside A is a microtubule-stabilizing agent with exceptional anti-migratory properties in human endothelial cells

Oncoscience

Volumn 2, Issue 6, 2015, Pages 585-595

  Ganguly, Anutosh ^a   Cabral, Fernando ^b   Yang, Hailing ^c   Patel, Kamala D ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b University of Texas Medical School   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Angiogenesis; Cell migration; Endothelial cells; Microtubule dynamics

Indexed keywords

EID: 84958532480     PISSN: None     EISSN: 23314737     Source Type: Journal    
DOI: 10.18632/oncoscience.169     Document Type: Article

References (29)

1. Jordan M A, Wilson L. Microtubules as a target for anticancer drugs. Nat. Rev. Cancer. 2004; 4: 253-265.
2. Ozols R F, Bundy B N, Greer B E, Fowler J M, Clarke-Pearson D, Burger R A, Mannel R S, DeGeest K, Hartenbach E M, Baergen R. Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study. J. Clin. Oncol. 2003; 21: 3194-3200.
3. Bekier M E, Fischbach R, Lee J, Taylor W R. Length of mitotic arrest induced by microtubule-stabilizing drugs determines cell death after mitotic exit. Mol. Cancer Ther. 2009; 8: 1646-1654.
4. Ganguly A, Yang H, Zhang H, Cabral F, Patel K D. Microtubule Dynamics Control Tail Retraction in Migrating Vascular Endothelial Cells. Mol. Cancer Ther. 2013; 12: 2837-2846.
5. Pasquier E, Andre N, Braguer D. Targeting Microtubules to Inhibit Angiogenesis and Disrupt Tumour Vasculature: Implications for Cancer Treatment. Curr. Cancer Drug Targets. 2007; 7: 566-581.
6. Jordan M A, Thrower D, Wilson L. Effects of vinblastine, podophyllotoxin and nocodazole on mitotic spindles. Implications for the role of microtubule dynamics in mitosis. J. Cell Sci. 1992; 102: 401-416.
7. Yang H, Ganguly A, Cabral F. Inhibition of Cell Migration and Cell Division Correlates with Distinct Effects of Microtubule Inhibiting Drugs. J. Biol. Chem. 2010; 285: 32242-32250.
8. Ganguly A, Yang H, Cabral F. Paclitaxel-Dependent Cell Lines Reveal a Novel Drug Activity. Mol. Cancer Ther. 2010; 9: 2914-2923.
9. Kapoor S, Panda D. Kinetic stabilization of microtubule dynamics by indanocine perturbs EB1 localization, induces defects in cell polarity and inhibits migration of MDA-MB-231 cells. Biochem. Pharmacol. 2012; 83: 1495-1506.
10. Hood K A, West L M, Rouwé B, Northcote P T, Berridge M V, Wakefield S J, Miller J H. Peloruside A, a Novel Antimitotic Agent with Paclitaxel-like Microtubule-stabilizing Activity. Cancer Res. 2002; 62: 3356-3360.
11. Huzil J T, Chik J K, Slysz G W, Freedman H, Tuszynski J, Taylor R E, Sackett D L, Schriemer D C. A Unique Mode of Microtubule Stabilization Induced by Peloruside A. J. Mol. Biol. 2008; 378: 1016-1030.
12. Best H A, Matthews J H, Heathcott R W, Hanna R, Leahy D C, Coorey N V C, Bellows D S, Atkinson P H, Miller J H. Laulimalide and peloruside A inhibit mitosis of Saccharomyces cerevisiae by preventing microtubule depolymerisation-dependent steps in chromosome separation and nuclear positioning. Mol. Biosyst. 2013; 9: 2842-2852.
13. Zhu Y, Zhou Y, Shi J. Post-slippage multinucleation renders cytotoxic variation in anti-mitotic drugs that target the microtubules or mitotic spindle. Cell Cycle Georget. Tex. 2014; 13: 1756-1764.
14. Ganguly A, Yang H, Sharma R, Patel K D, Cabral F. The Role of Microtubules and Their Dynamics in Cell Migration. J. Biol. Chem. 2012; 287: 43359-43369.
15. Ganguly A, Yang H, Cabral F. Class III ß-Tubulin Counteracts the Ability of Paclitaxel to Inhibit Cell Migration. Oncotarget. 2011; 2: 368-377.
16. Arnaoutova I, George J, Kleinman H K, Benton G. The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art. Angiogenesis. 2009; 12: 267-274.
17. Zeng Z, Inoue K, Sun H, Leng T, Feng X, Zhu L, Xiong Z-G. TRPM7 regulates vascular endothelial cell adhesion and tube formation. Am. J. Physiol. - Cell Physiol. 2015; 308: C308-C318.
18. Jordan M A, Wilson L. Microtubules and actin filaments: dynamic targets for cancer chemotherapy. Curr. Opin. Cell Biol. 1998; 10: 123-130.
19. Zacherl J, Hamilton G, Thalhammer T, Riegler M, Cosentini E P, Ellinger A, Bischof G, Schweitzer M, Teleky B, Koperna T. Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC 833 in dependence on extracellular pH. Cancer Chemother. Pharmacol. 1994; 34: 125-132.
20. Monzó M, Rosell R, Sánchez J J, Lee J S, O'Brate A, González-Larriba J L, Alberola V, Lorenzo J C, Núñez L, Ro J Y, Martín C. Paclitaxel Resistance in Non-Small-Cell Lung Cancer Associated With Beta-Tubulin Gene Mutations. J. Clin. Oncol. 1999; 17: 1786-1786.
21. Hari M, Wang Y, Veeraraghavan S, Cabral F. Mutations in alpha- and beta-tubulin that stabilize microtubules and confer resistance to colcemid and vinblastine. Mol. Cancer Ther. 2003; 2: 597-605.
22. Cabral F, Abraham I, Gottesman M M. Isolation of a taxol-resistant Chinese hamster ovary cell mutant that has an alteration in alpha-tubulin. Proc. Natl. Acad. Sci. 1981; 78: 4388-4391.
23. Kavallaris M, Kuo D Y, Burkhart C A, Regl D L, Norris M D, Haber M, Horwitz S B. Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes. J. Clin. Invest. 1997; 100: 1282-1293.
24. Ganguly A, Yang H, Pedroza M, Bhattacharya R, Cabral F. Mitotic Centromere-associated Kinesin (MCAK) Mediates Paclitaxel Resistance. J. Biol. Chem. 2011; 286: 36378-36384.
25. Sanhaji M, Friel C T, Wordeman L, Louwen F, Yuan J. Mitotic centromere-associated kinesin (MCAK): a potential cancer drug target. Oncotarget. 2011; 2: 935-947.
26. Ganguly A, Cabral F. New insights into mechanisms of resistance to microtubule inhibitors. Biochim. Biophys. Acta BBA - Rev. Cancer. 2011; 1816: 164-171.
27. Kanakkanthara A, Wilmes A, O'Brate A, Escuin D, Chan A, Gjyrezi A, Crawford J, Rawson P, Kivell B, Northcote P T, Hamel E, Giannakakou P, Miller J H. Peloruside- and Laulimalide-Resistant Human Ovarian Carcinoma Cells Have ßI-Tubulin Mutations and Altered Expression of ßII- and ßIII-Tubulin Isotypes. Mol. Cancer Ther. 2011; 10: 1419-1429.
28. Evans D A, Welch D S, Speed A W H, Moniz G A, Reichelt A, Ho S. An Aldol-Based Synthesis of (+)-Peloruside A, A Potent Microtubule Stabilizing Agent. J. Am. Chem. Soc. 2009; 131: 3840-3841.
29. Ganguly A, Zhang H, Sharma R, Parsons S, Patel K D. Isolation of Human Umbilical Vein Endothelial Cells and Their Use in the Study of Neutrophil Transmigration Under Flow Conditions. J. Vis. Exp. 2012: 1-5.